1-844-989-PATH (7284)
Back
Why is Pfizer adding this new requirement for patients enrolled in a Medicare Part D/Medicare Advantage Plan in 2025?
Beginning in 2025 the benefit changes outlined in the Inflation Reduction Act will help many Medicare Part D/Medicare Advantage patients, including (1) the reduction of out-of-pocket prescription costs for covered medicines to $2,100 annually and (2) a voluntary option for enrollment in the… Read More
NEW & EFFECTIVE IMMEDIATELY: When is the new Certification and demonstration of MPPP enrollment and/or ICPAP denial required for Medicare Part D/Medicare Advantage patients?
All Medicare Part D/Medicare Advantage enrollees seeking access to the Pfizer Patient Assistance Program beginning for the 2025 enrollment year, must attest to and provide evidence of their enrollment in the Medicare Prescription Payment Plan. In addition, patients must apply to all applicable… Read More
NEW: Why is Pfizer requesting proof of MPPP enrollment and/or proof of denial from all applicable ICPAPs?
Pfizer’s PAP is a last resort, safety net program, for patients with the most financial need. As such, we encourage patients to explore all of their options, and if the patient’s prescription costs remain unaffordable after this, only then should patients consider applying for the PAP.
When and how can patients enroll in the voluntary Medicare Prescription Payment Plan?
Medicare beneficiaries have the option to enroll in the Medicare Prescription Payment Plan during the Medicare Part D/Medicare Advantage Open Enrollment Period (which began on October 15th, 2024), as well as at any time during the plan year. For more information on the Medicare Prescription Payment… Read More
The patient’s healthcare provider, specialty pharmacy, alternative funding resource, or others are telling the patient not to enroll in the Medicare Prescription Payment Plan. What should the patient do?
The decision to enroll in the Medicare Prescription Payment Plan is voluntary and completely up to the patient. If the patient chooses not to enroll in the Medicare Prescription Payment Plan, they will not be eligible for enrollment/re-enrollment in the Pfizer Patient Assistance Program. We… Read More
Pfizer made changes to the program in 2023 and 2024. Why is Pfizer making changes to the PAP again, in 2025?
Periodically, Pfizer reviews the PAP to confirm it is supporting the evolving needs of patients in a rapidly changing healthcare environment. These changes are a response to the Inflation Reduction Act which caps Medicare Part D/Medicare Advantage patients’ annual out of pocket prescription drug… Read More